← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
University Of Texas Health Science Center At Houston
$134,434,504
Total funding
104
Grants
Funding over time
peak $52.4M · FY2008–25$100M$75M$50M$25M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
DOD$130,281,835 · 94
NASA$1,877,811 · 4
USDA$1,309,356 · 2
DOE$965,502 · 4
By mechanism
—$134,434,504 · 104
Investigators at University Of Texas Health Science Center At Houston
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
TEXAS TRAINING AND TECHNOLOGY AGAINST TRAUMA AND TERRORISM (T5)$25,271,617
· FY2008 · Department of Defense
BIONANOSCAFFOLDS (BNS) FOR POST-TRAUMATIC OSTEOREGENERATION$6,279,859
· FY2009 · Department of the Army
TEXSHIELD: TEXAS SCIENCE, HUMANITARIAN INTERVENTION, EDUCATION, AND LEADERSHIP IN DISASTER$6,199,536
· FY2008 · Department of the Army
COVID-19 A RANDOMIZED PHASE 2 CLINICAL TRIAL OF HIF ACTIVATOR VADADUSTAT FOR PREVENTION OR TREATMENT OF ARDS IN HOSPITALIZED COVID-19 PATIENTS$5,150,618
· FY2021 · Defense Health Agency
BIOMARKERS PROGNOSTIC FOR ELEVATED INTRACRANIAL PRESSURE$3,889,060
· FY2011 · Department of Defense
TOPICAL RAPAMYCIN THERAPY TO ALLEVIATE CUTANEOUS MANIFESTATIONS OF TUBEROUS SCLEROSIS COMPLEX$3,563,700
· FY2011 · Department of Defense
ALLIANCE FOR NANOHEALTH COMPETITIVE RESEARCH PROGRAM$3,389,211
· FY2009 · Department of Defense
MISSION CONNECT MILD TBI TRANSLATIONAL RESEARCH CONSORTIUM$3,010,414
· FY2008 · Department of Defense
DEVELOPMENT OF HEMICHANNEL-TARGETING ANTIBODY THERAPIES FOR BREAST CANCER BONE METASTASIS$2,865,402
· FY2017 · Department of the Army
MICROVASCULAR BARRIER BIOMARKERS TO PREDICT ICP THERAPEUTIC INTENSITY AFTER SEVERE TBI...NEW AWARD. DISTRIBUTED 8/16/2019$2,846,530
· FY2019 · Defense Health Agency
THE MEDICAL NANOVECTOR RESEARCH AND DEVELOPMENT CENTER OF THE ALLIANCE FOR NANOHEALTH$2,698,627
· FY2008 · Department of Defense
MISSION CONNECT MILD TBI TRANSLATIONAL RESEARCH CONSORTIUM$2,684,840
· FY2008 · Department of Defense
NEUROMODULATION + PROLONGED EXPOSURE THERAPY: EVALUATION OF A TECHNOLOGY-ENHANCED ENTIRELY REMOTE 2-WEEK INTEGRATED TREATMENT FOR PAIN AND PTSD$2,346,267
· FY2025 · Defense Health Agency
10147002W23RYX0168N601 CHARACTERIZATION AND APPLICATION OF A LARGE ANIMAL MODEL OF PENETRATING BALLISTIC BRAIN INJURY (PBBI)$2,018,801
· FY2011 · Department of Defense
HEMORRHAGE CONTROL FOR MAJOR TRAUMATIC VASCULAR INJURIES$1,991,317
· FY2014 · Department of the Army
TEXAS TRAINING & TECHNOLOGY AGAINST TRAUMA & TERRORISM (T5)$1,916,249
· FY2008 · Department of Defense
BUILDING RESILIENCE IN CAREGIVERS OF TRAUMA SURVIVORS$1,887,757
· FY2017 · Defense Health Agency
LGR4 IN BREAST CANCER PROGRESSION AND THERAPY$1,858,998
· FY2017 · Department of the Army
TREATMENT OF ADULT SEVERE TRAUMATIC BRAIN INJURY USING AUTOLOGOUS BONE MARROW MONONUCLEAR CELLS$1,708,363
· FY2011 · Department of Defense
DEFINING FINAL COMMON PATHOGENETIC PATHWAY OF ENDONEURIAL INFLAMMATION AND NERVE INJURY IN MODELS OF IMMUNE NEUROPATHY$1,658,213
· FY2018 · Department of the Army